Additionally, we also found that expression of YAP (YAP1) was negatively correlated with ERα (ESR1) in ER+ breast cancer patients, but the ESR1 level was still positively correlated with YAP‐ and obesity‐associated signatures (Figure S8F, Supporting Information). Here, ESR1 is linked to breast carcinoma.